Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Eschbach

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|February 1, 1970
Ferrokinetics: a biologic model for plasma iron exchange in manJ D Cook, G Marsaglia, J W Eschbach, et al.
Kidney International|May 1, 1988
The anemia of end-stage renal disease: hematopoietic progenitor cell responseG M Segal, J W Eschbach, J C Egrie, et al.
Annals of Internal Medicine|November 1, 1970
The importance of patient training in home hemodialysisC R Blagg, S M Daly, B J Rosenquist, et al.
Contributions to Nephrology|January 1, 1989
USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patientsJ W Eschbach, M R Downing, J C Egrie, et al.
The New England Journal of Medicine|January 8, 1987
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialJ W Eschbach, J C Egrie, M R Downing, et al.
American Journal of Hypertension|December 1, 1990
Hypertension following erythropoietin therapy in anemic hemodialysis patientsF S Buckner, J W Eschbach, N R Haley, et al.
The New England Journal of Medicine|July 20, 1989
Treatment of the anemia of progressive renal failure with recombinant human erythropoietinJ W Eschbach, M R Kelly, N R Haley, et al.
Contributions to Nephrology|January 1, 1991
The safety of epoetin-alpha: results of clinical trials in the United StatesJ W Eschbach, J C Egrie, M R Downing, et al.
Clinical Nephrology|February 1, 1993
Effects of erythropoietin on strength and functional status of patients on hemodialysisM Guthrie, D Cardenas, J W Eschbach, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1990
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patientsH T Robertson, N R Haley, M Guthrie, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|February 1, 1970
Ferrokinetics: a biologic model for plasma iron exchange in manJ D Cook, G Marsaglia, J W Eschbach, et al.
Kidney International|May 1, 1988
The anemia of end-stage renal disease: hematopoietic progenitor cell responseG M Segal, J W Eschbach, J C Egrie, et al.
Annals of Internal Medicine|November 1, 1970
The importance of patient training in home hemodialysisC R Blagg, S M Daly, B J Rosenquist, et al.
Contributions to Nephrology|January 1, 1989
USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patientsJ W Eschbach, M R Downing, J C Egrie, et al.
The New England Journal of Medicine|January 8, 1987
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialJ W Eschbach, J C Egrie, M R Downing, et al.
American Journal of Hypertension|December 1, 1990
Hypertension following erythropoietin therapy in anemic hemodialysis patientsF S Buckner, J W Eschbach, N R Haley, et al.
The New England Journal of Medicine|July 20, 1989
Treatment of the anemia of progressive renal failure with recombinant human erythropoietinJ W Eschbach, M R Kelly, N R Haley, et al.
Contributions to Nephrology|January 1, 1991
The safety of epoetin-alpha: results of clinical trials in the United StatesJ W Eschbach, J C Egrie, M R Downing, et al.
Clinical Nephrology|February 1, 1993
Effects of erythropoietin on strength and functional status of patients on hemodialysisM Guthrie, D Cardenas, J W Eschbach, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1990
Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patientsH T Robertson, N R Haley, M Guthrie, et al.
Pageof 6